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ABSTRACT  
Circulating tumor cell (CTC) clusters arise from multicellular grouping in the primary tumor and elevate the metastatic 
potential by 23 to 50 fold compared to single CTCs. High throughout detection and quantification of CTC clusters is 
critical for understanding the tumor metastasis process and improving cancer therapy. In this work, we report a linear-
array-based photoacoustic tomography (LA-PAT) system capable of label-free high-throughput CTC cluster detection 
and quantification in vivo. LA-PAT detects CTC clusters and quantifies the number of cells in them based on the 
contrast-to-noise ratios (CNRs) of photoacoustic signals. The feasibility of LA-PAT was first demonstrated by imaging 
CTC clusters ex vivo. LA-PAT detected CTC clusters in the blood-filled microtubes and computed the number of cells in 
the clusters. The size distribution of the CTC clusters measured by LA-PAT agreed well with that obtained by optical 
microscopy. We demonstrated the ability of LA-PAT to detect and quantify CTC clusters in vivo by imaging injected 
CTC clusters in rat tail veins. LA-PAT detected CTC clusters immediately after injection as well as when they were 
circulating in the rat bloodstreams. Similarly, the numbers of cells in the clusters were computed based on the CNRs of 
the photoacoustic signals. The data showed that larger CTC clusters disappear faster than the smaller ones. The results 
prove the potential of LA-PAT as a promising tool for both preclinical tumor metastasis studies and clinical cancer 
therapy evaluation.   
Keywords: photoacoustic tomography, cancer metastasis, circulating tumor cell, cancer therapy 
 
1. INTRODUCTION  
The majority of cancer deaths are associated with metastasis, the process in which the cancer cells spread from a primary 
site to distant organs and lead to the growth of new tumors there1. During metastasis, cancer cells need to survive the 
intravasation, circulation in the blood, extravasation, and secondary growth in the distant organs. Thus, the rare 
circulating cancer cells (CTCs) are the key determinants of the metastatic propensity2. While previously CTCs are 
considered to exist mostly in single cells, recent studies have found that CTC clusters also exist and elevate the 
metastatic potential by 23 to 50 fold3. They arise from the multicellular grouping in the primary tumor and can traverse 
capillary-sized vessels4. Detection and quantification of CTC clusters will provide valuable insights into metastasis as 
well as cancer therapy. 
Taking advantage of tumor-specific physical and biological properties, such as sizes and surface biomarkers, multiple 
technologies have been developed to capture and isolate single CTCs and CTC clusters5-7. However, most of these 
existing technologies require blood to be drawn to isolate and capture CTCs ex vivo, reducing the effective CTC 
detection sensitivity. Optical imaging technologies, such as confocal microscopy, in vivo flow cytometry, and optical 
coherence tomography, have been applied to detect CTCs in vivo8-11. However, suffering from strong optical scattering in 
biological tissue, these techniques have shallow penetration, limiting them to imaging only small blood vessels, which 
results in low throughput for CTC detection. 
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By integrating optical excitation with acoustic detection, photoacoustic tomography (PAT) combines rich optical 
absorption contrasts with high ultrasonic spatial resolution at depths12. With 100% relative sensitivity to optical 
absorption, i.e., a given percentage change in the optical absorption yields the same percentage change in the 
photoacoustic signal, PAT achieves structural, functional, metabolic, and mechanical imaging of biological tissue13-17. 
Taking advantage of the strong optical absorption of melanin, photoacoustic techniques have been successfully used for 
imaging and sensing melanoma CTCs. Photoacoustic flowmetry successfully detected circulating melanoma cells in 
human blood18, 19. Photoacoustic flow cytometry enables long-term monitoring of melanoma CTCs in vivo. However, 
these sensing techniques provide inadequate spatial resolution to further characterize melanoma CTCs20. The 
microscopic implementation of PAT, optical-resolution photoacoustic microscopy (OR-PAM), images single melanoma 
CTCs in the blood flows with high spatial-temporal resolution21. While providing valuable insights into CTCs on a 
single-cell level, OR-PAM suffers from low throughput. 
Here, we apply a linear-array-based photoacoustic tomography (LA-PAT) system for label-free high-throughput 
melanoma CTC cluster detection and quantification in vivo. Exploiting the strong optical absorption of melanin in the 
melanoma tumor cells, LA-PAT can achieve label-free detection of melanoma CTC clusters in vivo. By analyzing the 
contrast-to-noise ratios (CNRs) of the photoacoustic signals, LA-PAT can quantify the number of cells in the CTC 
clusters and study their circulating kinetics in the bloodstream. 
2. MATERIALS AND METHODS 
2.1 Experimental system 
To image melanoma CTC clusters, we applied an LA-PAT system based on a handheld probe and improved the image 
reconstruction22, 23. A tunable optical parametric oscillator laser (680 to 970 nm, 20-Hz pulse repetition rate) was used for 
illumination. The laser beam was coupled into a fiber optical bundle that bifurcated into two optical fiber bundles. Laser 
beams coming out of the two optical fiber bundle strips (20 × 1.25 mm2) excited the object at an angle of incidence of 30 
degree relative to the imaging plane [Figs. 1(a) and 1(b)]. During the experiments, the fluence on the tissue surface was 
about 10 mJ/cm2, well within the 20 mJ/cm2 safety limit set by the American National Standards Institute. The generated 
photoacoustic waves were detected by a linear array ultrasonic transducer (Visualsonics, Inc., LZ250, 21-MHz center 
frequency, 78% one-way bandwidth, 256 elements, 23 × 3 mm2 array size). The spatial resolutions of the system were 
119 μm in the lateral direction, 86 μm in the axial direction, and 1237 μm in the elevational direction24. Because there 
were only 64 channels in the data acquisition unit, four-to-one multiplexing was applied during image acquisition. For 
each laser pulse, the generated photoacoustic signals were captured sequentially by a quarter segment of the linear array 
(i.e., elements 1 to 64, 65 to 128, 129 to 192, and 193 to 256). Once the data were acquired from all four quarter 
segments, a two-dimensional photoacoustic image was reconstructed with the universal back-projection algorithm 
developed by our group25. The reconstructed photoacoustic images were displayed in an imaging station (Vevo LAZR, 
Visualsonics, Inc.). Determined by the 20-Hz laser repetition rate and the four-to-one multiplexing in image acquisition, 
the frame rate was 5 frames/s. 
 
Figure 1. Front and side views of the linear-array-based photoacoustic tomography (LA-PAT) system with a handheld probe. 
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2.2 Tumor cell culture and cluster preparation 
B16F10 melanoma tumor cells obtained from ATCC® were cultured in Dulbecco’s modified Eagle’s medium (Invitrogen) 
supplemented with 10% fetal bovine serum (Invitrogen) at 37°C in air with 5% CO2. Upon reaching 80% confluence, 
cells growing in a monolayer were incubated with 0.25% trypsin-EDTA solution (Invitrogen) to generate floating cell 
clusters of various sizes. After adding serum-containing medium to neutralize trypsin, the floating cell clusters were 
handled in two ways. To mimic melanoma CTC clusters of various sizes, floating cell clusters totaling 1 × 106 cells were 
directly suspended in 1 mL of bovine blood for ex vivo experiments or in 1 mL of collected rat blood for tail vein 
injection. To generate melanoma cell clusters of a certain size for CNR analysis, instead of directly suspending the 
floating cell clusters in blood, the clusters were mechanically dissociated by pipetting to generate a single-cell 
suspension. The single cells were then suspended in a blood–agar mixture at a desired concentration and then cooled to 
become solid. The concentration was controlled so that within each resolution voxel of LA-PAT there was a certain 
number of melanoma cells, i.e., 5, 10, 20, 30, 40, or 50. The solid mixture was then mechanically dissociated into 
particles smaller than the resolution voxel of LA-PAT to generate cell clusters of a certain size. The particles were then 
suspended in 1 mL of bovine blood for CNR analysis. 
2.3 Phantom preparation 
Silicone microtubes with 0.76 mm inner diameter (11-189-15C, Fisher Scientific) were perfused with bovine blood (905, 
Quad-Five) to mimic blood vessels. The microtubes were embedded 3 mm deep in tissue-mimicking gelatin phantoms. 
Optical scattering similar to that in biological tissue was achieved by adding 1% intralipid to the gelatin phantoms. 
Melanoma tumor cell clusters suspended in bovine blood were pumped through the microtubes with a syringe. A syringe 
pump (BSP-99M, Braintree Scientific) controlled the blood flow speed. 
2.4 Experimental animals and CTC cluster injection 
All experimental animal procedures were carried out in conformity with the laboratory animal protocol approved by the 
Animal Studies Committee at Washington University in St. Louis. Male nude rats (Hsd:RH-Foxn1rnu/Foxn1+, Harlan Co.; 
12- to 13-weeks old; ~330 to 350 g body weight) were used for all in vivo experiments. Throughout the experiments, the 
rats were kept under anesthesia with 2% vaporized isoflurane. A homemade animal holder immobilized the rats during 
the experiments. 
3. RESULTS 
3.1 Optimal wavelength for CTC cluster detection 
To maximize the melanoma CTC cluster detection sensitivity, the illumination wavelength should be chosen carefully. 
Since the major optical absorber in blood is hemoglobin, we compared the optical absorption spectra of melanin, major 
optical absorber in melanoma tumor cells, and hemoglobin [Fig. 2(a)]. The optical absorption coefficient ratio of melanin 
and venous blood with oxygen saturation level of 85% was calculated [Fig. 2(b)]. The venous blood was chosen because 
veins are ideal targets for detecting melanoma tumor cells with shallow depth in tissue and large blood volume. Based on 
the results, 680 nm was chosen to maximize the CTC cluster detection sensitivity.  
3.2 CNR analysis of melanoma tumor cell clusters 
To detect and quantify CTC clusters, we first used LA-PAT to image melanoma tumor cell clusters of known sizes and 
analyzed their CNRs. Clusters with an average of 5, 10, 20, 30, 40, and 50 cells were suspended in blood and imaged by 
LA-PAT. The CNR for each cluster was calculated [Fig. 3(a)]. The average CNRs were plotted as a function of the 
number of cells in the clusters, as measured with an optical microscope (OM) (Eclipse TS100, Nikon) [Fig. 3(b)]. The 
experimental data were fitted to a linear function 
 NCNR ×= 46.0 . (1) 
Here, N represents the number of cells in a melanoma tumor cell cluster. Based on a 6-dB CNR threshold, a minimum of 
four cells can be resolved although this minimum was not directly observed. To verify the relationship between the CNR 
and the number of cells in the clusters, another independent experiment was performed. Melanoma tumor cell clusters 
consisting of a uniform but unknown number of cells were equally divided into six groups. Three randomly chosen 
groups were suspended in blood and imaged by LA-PAT. The numbers of cells in the clusters were calculated based on 
the CNRs and the relationship above. The other three groups were examined with an OM to determine the numbers of 
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cells in the clusters. The number of cells in the melanoma tumor cell clusters measured by LA-PAT and optical 
microscopy agreed well with each other [Fig. 4], confirming the relationship between the numbers of cells in the clusters 
and the CNRs in LA-PAT. 
 
Figure 2. Absorption spectra of melanin and hemoglobin and absorption coefficient ratio of melanin and blood with 
oxygen saturation (sO2) level of 85%. (a) Absorption spectra of melanin and hemoglobin from 250 nm to 1000 nm. (b) 
Absorption coefficient ratio of melanin and blood with sO2 of 85%. An excitation wavelength of 680 nm was chosen to 
maximize the melanoma CTC detection sensitivity.  
 
Figure 3. Contrast-to-noise ratio (CNR) analysis of melanoma tumor cell clusters. (a) CNR distribution of melanoma 
tumor cell clusters of different sizes by LA-PAT. (b) Average CNRs as a function of the numbers of cells in melanoma 
tumor cell clusters. 
3.3 LA-PAT of CTC clusters ex vivo 
We then demonstrated the ability of LA-PAT to detect and quantify CTC clusters ex vivo. A mixture of melanoma tumor 
cell clusters of various sizes was equally divided into six groups. Three randomly chosen groups were suspended in 
blood, pumped through microtubes to mimic flowing melanoma CTC clusters, and imaged by LA-PAT. Each melanoma 
tumor cell cluster was captured by LA-PAT multiple times, and the average CNR was used to calculate the number of 
cells in the cluster. Based on the calculated number of cells in the clusters, the melanoma tumor cell clusters were 
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divided into three categories: ≤10, 11 to 20, and ≥21. Typical photoacoustic images of the three categories are shown 
in Figs. 5(a)–5(c). The other three groups were measured with an OM to determine the numbers of cells in the clusters 
and were divided into the same three categories. The size distributions of the clusters measured by LA-PAT and optical 
microscopy agreed well with each other with a correlation coefficient of 0.96 [Fig. 5(d)], and the results further 
demonstrated the ability of LA-PAT to detect and quantify melanoma CTC clusters. 
 
Figure 4. The numbers of cells in melanoma tumor cell clusters measured by LA-PAT agreed well with those measured by 
optical microscopy (OM).  
 
Figure 5. LA-PAT of CTC clusters ex vivo. LA-PAT of flowing melanoma tumor cell clusters with (a) 7 cells, (b) 14 cells, 
and (c) 29 cells. The cell numbers are calculated based on Eq. (1). (d) Distributions of the numbers of cells in melanoma 
tumor cell clusters, as measured by LA-PAT and OM. 
3.4 LA-PAT of CTC clusters in vivo 
To demonstrate the feasibility of LA-PAT in vivo, we imaged melanoma CTC clusters injected into rats. Melanoma 
tumor cell clusters suspended in 1 mL of rat blood at a concentration of 1 ×106 cells/mL were injected into the same rat 
from which the blood was collected a few minutes earlier. The rat tail vein was then monitored by LA-PAT for 45 min to 
study the circulation kinetics and the clearance rates of CTC clusters. CTC clusters were detected by LA-PAT 
immediately after injection and during circulating in the rat bloodstreams [Figs. 6(a) and 6(b)]. The numbers of cells in 
the CTC clusters were calculated based on the CNRs. The CTC clusters were categorized into three groups based on the 
calculated number of cells and the clearance curves of the three groups are shown in Fig. 6(c). Larger CTC clusters 
disappeared faster than smaller ones. 
4. DISCUSSIONS AND CONCLUSIONS 
Compared with single CTCs, CTC clusters are rarer, but have a higher metastatic potential. CTC clusters have a faster 
clearance rate, i.e., a shorter lifetime, in the bloodstream than single CTCs, making them even more difficult to detect. 
Here, we applied LA-PAT to detect and quantify melanoma CTC clusters in rat in vivo. Since the spatial resolutions of 
LA-PAT were not enough to resolve single melanoma tumor cells, the numbers of cells in the CTC clusters were 
quantified based on the CNRs. A linear relationship between the CNRs and the numbers of cells in the CTC clusters was 
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found and verified. In ex vivo experiments, LA-PAT quantified the numbers of cells in the CTC clusters, and the results 
were validated by an OM. In experiments in vivo, LA-PAT detected and quantified melanoma CTC clusters immediately 
after injection, as well as when they were circulating in the rat bloodstreams. The results by LA-PAT also showed that 
larger CTC clusters disappeared faster than smaller ones. 
 
Figure 6. LA-PAT of CTC clusters in rat tail veins in vivo. (a) LA-PAT of CTC clusters in a rat tail vein in vivo 
immediately after injection. (b) LA-PAT of CTC clusters in the rat tail vein in vivo 45 min after injection. (c) Clearance 
curves of small (≤10 cells), medium (11 to 20 cells), and large (≥21 cells) CTC clusters in rat bloodstreams. 
The melanoma CTC detection sensitivity of LA-PAT is determined by the CNR. Because the noise is dominated by the 
fluctuating counts of red blood cells in each resolution voxel, the detection sensitivity is largely dependent on the spatial 
resolutions of LA-PAT. On one hand, to achieve single cell sensitivity in CTC detection, a higher frequency ultrasonic 
transducer could be used at the expense of penetration depth. On the other hand, to achieve deeper imaging, a lower 
frequency ultrasonic transducer can be employed, at the expense of CTC detection sensitivity. The CTC detection 
sensitivity can be further improved by performing spectral unmixing using multi-wavelength illumination. To achieve 
multi-wavelength imaging of flowing CTCs, a second laser with a different wavelength needs to be incorporated into the 
system. 
It is worth pointing out that currently LA-PAT detects only CTCs originating from primary tumors in which cells 
express melanin. To detect CTCs originating from amelanotic melanoma tumors, other tumor-specific physiological 
properties, such as sizes and surface biomarkers, can be utilized. The quantification of CTC cluster sizes is indeed based 
on the assumption that the melanin content is relatively uniform in the tumor cells. This assumption often holds true for 
tumor cells originating from the same primary tumor. However, if there are several primary tumors, it may affect the 
accuracy of quantifying CTC cluster sizes. 
LA-PAT has the potential to be a powerful tool for both preclinical tumor metastasis study and clinical cancer diagnosis 
and therapy. As a useful technique for researchers and scientists to better understand the relationship between CTCs and 
tumor metastasis, LA-PAT can employ ultrasonic transducers of different frequencies for target vessels at various depths 
and different animal models. Other physiological parameters, including vessel diameter and blood flow speed, can be 
measured concurrently for further understanding of CTC flow dynamics. LA-PAT can also be used by clinicians to 
monitor the changes of CTC concentrations in patients’ circulatory systems and to evaluate the outcome of cancer 
therapy. To further improve LA-PAT for such clinical applications, an automatic CTC detection and counting algorithm 
should be developed. 
Metastasis is a complex biological process that involves multiple steps and many parameters. Photoacoustic imaging, 
with the ability to quantify numerous parameters at multiple scales based on the same optical absorption contrast, can 
provide comprehensive information about tumor metastasis. OR-PAM can study CTCs on a single-cell level21. LA-PAT 
has been demonstrated to detect and quantify CTC clusters. In addition, photoacoustic imaging can measure other 
important biological parameters, including tumor depth, the oxygen saturation of hemoglobin, metabolic rate, and tumor 
stiffness26-29, all of which are closely related to metastasis30-32. With the capability to detect and quantify CTC clusters 
and the potential to provide multidimensional information on tumor metastasis, LA-PAT is a promising tool for both 
preclinical cancer metastasis study and clinical tumor therapy. 
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